상세 보기
SEZanne: A phase 2 randomized, open-label, multicenter study to evaluate the optimal dose, safety, and efficacy of ABBV-706 in combination with atezolizumab (atezo) versus standard of care (SOC) in patients (pts) with previously untreated extensive-stage (ES) small cell lung cancer (SCLC).
- Cuppens, Kristof;
- Byers, Lauren Averett;
- Goto, Yasushi;
- Ardizzoni, Andrea;
- Paz-Ares, Luis G.;
- ... Lee, Se-Hoon;
- 외 11명
Citations
WEB OF SCIENCE
1- 제목
- SEZanne: A phase 2 randomized, open-label, multicenter study to evaluate the optimal dose, safety, and efficacy of ABBV-706 in combination with atezolizumab (atezo) versus standard of care (SOC) in patients (pts) with previously untreated extensive-stage (ES) small cell lung cancer (SCLC).
- 저자
- Cuppens, Kristof; Byers, Lauren Averett; Goto, Yasushi; Ardizzoni, Andrea; Paz-Ares, Luis G.; Zhou, Caicun; Dowlati, Afshin; Cooper, Alissa Jamie; Bar, Jair; Lee, Se-Hoon; Jahchan, Nadine; Zhao, Ye; Meiman, Darius; Fang, Fang; Rivell, Guillermo; Palenski, Tammy; Chiang, Anne C.
- 발행일
- 2026-06-01
- 유형
- Meeting Abstract
- 권
- 44
- 호
- 16_SUPPL
- 페이지
- TPS8135 ~ TPS8135
- 언어
- ENG
- 출판사
- LIPPINCOTT WILLIAMS & WILKINS
- 발행국가
- 미국
- ISSN
- E 1527-7755
P 0732-183X